Immunomodulatory Therapies in Hypersensitivity Pneumonitis: A Comprehensive Review

Hypersensitivity pneumonitis (HP) is an immune-mediated interstitial lung disease (ILD) caused by repeated inhalation of environmental antigens. Clinically, it varies widely from temporary, reversible inflammation to long-term, progressive fibrosis. The primary approach in managing HP remains identi...

Descripció completa

Dades bibliogràfiques

Autors principals:	Sanket Joshi, Dipti Gothi, Manika Sachdeva
Format:	Artigo
Idioma:	Inglês
Publicat:	Mashhad University of Medical Sciences 2026-03-01
Col·lecció:	Journal of Cardio-Thoracic Medicine
Matèries:	antifibrotic hypersensitivity pneumonitis immunomodulation interstitial lung disease rituximab
Accés en línia:	https://jctm.mums.ac.ir/article_26916_4778d601b4e398cb258980dd37e76520.pdf
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!